ResMed announces results for fourth quarter and fiscal year 2015
ResMed reported revenue for FY 2015 was $1.7 billion, an 8 percent increase compared with the prior year. Net income was $352.9 million in 2015, a 2% increase compared with 2014. Diluted earnings per share for the year were $2.47, a 3% increase compared with the year ended June 30, 2014. July 30, 2015